Biotech Acquisition Company (BIOT)
| Market Cap | 223.10M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 23.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,124 |
| Open | 9.70 |
| Previous Close | 9.71 |
| Day's Range | 9.66 - 9.70 |
| 52-Week Range | 9.54 - 9.95 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About BIOT
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
News
Biotech Acquisition Company Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 1...
NEW YORK, March 15, 2021 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOTU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial public ...
Biotech Acquisition Company Announces Closing of $230,000,000 Initial Public Offering
New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units ...
Biotech Acquisition Company Announces Pricing of $200 Million Initial Public Offering
New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acqui...
SPRIM-backed SPAC Biotech Acquisition files for a $200 million IPO
Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.
Biotech Acquisition IPO Registration Document (S-1)
Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.